Posted by Michael Wonder on 18 Feb 2021
Johnson & Johnson has only a few million COVID-19 vaccine doses in stock as likely launch nears
18 February 2021 - Johnson & Johnson has only a few million doses of its experimental COVID-19 vaccine in its inventory even as likely U.S. regulatory authorisation is only a few weeks away, White House officials said on Wednesday.
J&J remains committed to providing 100 million doses by June but deliveries are likely to be “back-end loaded” as J&J works with the U.S. government to boost supply, Jeffrey Zients, the White House’s COVID-19 response coordinator, said during a press call.
